TTK Healthcare Ltd. Stock Hits 52-Week Low Amidst Continued Downtrend

Recent Price Movement and Market Context

On 10 March 2026, TTK Healthcare’s stock closed near its 52-week low, underperforming its sector by 2.19% and registering a day change of -0.85%. The stock has declined for two consecutive sessions, losing 1.99% over this period. Intraday, it reached a low of Rs 844.75, marking a 3.17% drop from the previous close. The share price currently trades below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downtrend across short and long-term technical indicators.

The broader market environment has been challenging as well. The Nifty index closed at 24,261.60, up 0.97% on the day, but it has experienced a three-week consecutive fall, losing 5.12% over this period. Despite gains across all market capitalisation segments, led by the Nifty Small Cap 100 index rising 2.12%, TTK Healthcare’s performance remains subdued.

Long-Term Performance and Relative Comparison

Over the past year, TTK Healthcare has delivered a negative return of 24.91%, significantly lagging behind the Sensex, which posted a 5.52% gain in the same timeframe. The stock’s 52-week high stands at Rs 1,398.90, highlighting the extent of the recent decline. This underperformance extends beyond the last year, with the stock also trailing the BSE500 index over the last three years, one year, and three months.

Financial Metrics and Growth Trends

TTK Healthcare’s long-term growth has been modest, with net sales increasing at an annual rate of 6.99% and operating profit growing at 15.42% over the last five years. The company reported flat results in the December 2025 half-year period. Cash and cash equivalents stood at Rs 600.89 crore, marking the lowest level in recent periods. The debtors turnover ratio also declined to 7.40 times, the lowest recorded in the half-yearly data.

Non-operating income accounted for a significant 80.43% of profit before tax in the latest quarter, indicating a reliance on income sources outside core operations. Despite the company’s size, domestic mutual funds hold a minimal stake of just 0.01%, which may reflect limited confidence or interest at current price levels.

Valuation and Profitability Indicators

TTK Healthcare maintains a low average debt-to-equity ratio of zero, reflecting a debt-free capital structure. The return on equity (ROE) is 6.5%, which, combined with a price-to-book value of 1.1, suggests an attractive valuation relative to book value. However, the stock trades at a premium compared to its peers’ historical averages. Over the past year, profits have increased by 2.4%, yet the price-to-earnings-to-growth (PEG) ratio is elevated at 7.5, indicating that earnings growth has not kept pace with the stock’s valuation.

Technical Analysis Overview

Technical indicators predominantly signal bearish momentum. The Moving Average Convergence Divergence (MACD) is bearish on both weekly and monthly charts. Bollinger Bands also indicate bearish trends across these timeframes. The daily moving averages confirm a bearish stance, while the Know Sure Thing (KST) indicator is bearish on weekly and monthly scales. Dow Theory assessments show mild bearishness, and the On-Balance Volume (OBV) indicator reveals no clear trend weekly and mild bearishness monthly. The Relative Strength Index (RSI) is bullish on a monthly basis but lacks confirmation on the weekly chart.

Market Capitalisation and Mojo Score

TTK Healthcare holds a market cap grade of 4, reflecting its mid-tier capitalisation status within the diversified sector. The company’s Mojo Score stands at 37.0, with a Mojo Grade of Sell, downgraded from Hold on 21 July 2025. This downgrade aligns with the stock’s recent price weakness and subdued financial performance.

Summary of Key Concerns

The stock’s proximity to its 52-week low, combined with underperformance relative to sector and benchmark indices, highlights ongoing challenges. The modest growth rates in sales and operating profit, coupled with flat recent results and a high proportion of non-operating income, suggest limited momentum in core business activities. The low engagement from domestic mutual funds further underscores subdued market interest.

Conclusion

TTK Healthcare Ltd.’s stock has experienced a notable decline, reaching levels close to its 52-week low amid a broader market environment that has seen mixed performances. The company’s financial metrics and technical indicators predominantly point to a cautious outlook, with valuation and profitability measures reflecting a complex picture. While the stock maintains some attractive features such as low debt and reasonable price-to-book value, the overall trend remains subdued as reflected in recent price action and market sentiment.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →